Developments in Prostate Cancer Screening

24 min
at 10:00 AM
 (Photo: Getty Images)

The U.S. Preventive Services Task Force recently finalized their recommendation that men ages 55 to 69 should speak with their health care providers about prostate cancer screening using the prostate-specific antigen, or PSA. We'll discuss the latest on the procedure, which has a significant problem with false positives. We discuss the latest on the procedure, which has a significant problem with false positives, and hear about developments in research on prostate cancer.
Guests:
Dr. Paul Alpert,
clinical professor, department of urology, UCSF Medical Center
Dr. Mark S. Litwin, professor of urology and public health and urology department chair, UCLA

Related Links:
New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients (Urology Journal)

Sponsored

Sponsored

Volume
KQED Live
Live Stream
Log In ToPledge-Free Stream
LATEST NEWSCAST
KQED
NPR
Live Stream information currently unavailable.
Share
LATEST NEWSCAST
KQED
NPR
KQED Live

Live Stream

Live Stream information currently unavailable.